The U.S. Food and Drug Administration approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In